Nitrogen + Oxygen Compounds (N + O)
Found 698,656 compounds containing Nitrogen + Oxygen. Page 1408 of 13974.
N
Nitrogen
78% of atmosphere
O
Oxygen
Essential for respiration
| Formula | IUPAC Name | Common Name | Mol. Weight |
|---|---|---|---|
| C13H17NO2 | 2-(5-methoxybenzofuran-3-yl)-N,N-dimethyl-ethanamine | 140853-58-3 | 219.28 |
| C12H20N2O4 | 1-[(4S,5S)-5-(hydroxymethyl)-4-(methylamino)tetrahydrofuran-2-yl]-5-methyl-piperidine-2,4-dione | 1-[(4S,5S)-5-(hydroxymethyl)-4-(methylamino)tetrahydrofuran-2-yl]-5-methyl-piperidine-2,4-dione | 256.30 |
| C8H11N3O4 | 4-amino-1-[(2R)-2-(hydroxymethyl)-1,3-dioxolan-4-yl]pyrimidin-2-one | Bch 4556 | 213.19 |
| C11H13N5O4 | 2-amino-9-[(4S,5R)-4-hydroxy-5-(hydroxymethyl)-3-methylene-tetrahydrofuran-2-yl]-3H-purin-6-one | 2-amino-9-[(4S,5R)-4-hydroxy-5-(hydroxymethyl)-3-methylene-tetrahydrofuran-2-yl]-3H-purin-6-one | 279.25 |
| C17H27NO4 | [4-methoxy-5-methyl-2-(1-methylhepta-1,3,5-trienyl)tetrahydropyran-3-yl] 2-aminoacetate | (4-Methoxy-5-methyl-2-octa-2,4,6-trien-2-yloxan-3-yl) 2-aminoacetate | 309.40 |
| C12H21N3O5S | N-[(2S,3R,4R,5R,6R)-4,5-dihydroxy-6-(hydroxymethyl)-2-[2-(3-methyldiazirin-3-yl)ethylsulfanyl]tetrahydropyran-3-yl]acetamide | 3-Aagtb | 319.38 |
| C12H21N3O5S | N-[(2S,3R,4R,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-2-[2-(3-methyldiazirin-3-yl)ethylsulfanyl]tetrahydropyran-3-yl]acetamide | Aadgtb | 319.38 |
| C18H28Cl3NO | 4-[2-(3,4-dichlorophenoxy)ethyl]-1-pentyl-piperidine;hydrochloride | 141429-64-3 | 380.80 |
| C18H27Cl2NO | 4-[2-(3,4-dichlorophenoxy)ethyl]-1-pentyl-piperidine | 4-[2-(3,4-dichlorophenoxy)ethyl]-1-pentylpiperidine | 344.30 |
| C18H17N3O3S | N-(2-anilino-3-pyridyl)-4-methoxy-benzenesulfonamide | CHEMBL84116 | 355.40 |
| C17H13ClN4O | 3-(8-chloro-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepin-6-yl)phenol | 141490-47-3 | 324.80 |
| C15H21BrN2O3 | 2-(diethylamino)ethyl 4-[(2-bromoacetyl)amino]benzoate | 4-Bromoacetamidoprocaine | 357.24 |
| C11H15Cl2NOS | N,N-bis(2-chloroethyl)-4-methylsulfinyl-aniline | Msp-dijon | 280.20 |
| C11H15N4O8P | [(2R,3S,4R)-3,4-dihydroxy-5-(6-oxo-3H-purin-9-yl)tetrahydrofuran-2-yl]methyl methyl hydrogen phosphate | [(2R,3S,4R)-3,4-dihydroxy-5-(6-oxo-3H-purin-9-yl)tetrahydrofuran-2-yl]methyl methyl hydrogen phosphate | 362.23 |
| C17H14N2O4 | [4-(3,4-dimethylisoxazol-5-yl)imino-1-oxo-2-naphthyl] acetate | 141723-90-2 | 310.30 |
| C11H10FNO4 | (2,5-dioxopyrrolidin-1-yl) 4-(18F)fluorocyclohexa-2,5-diene-1-carboxylate | (2,5-dioxopyrrolidin-1-yl) 4-(18F)fluorocyclohexa-2,5-diene-1-carboxylate | 238.20 |
| C9H13N3O | 1-ethyl-3-(6-methyl-2-pyridyl)urea | 2-(3-Ethylureido)-6-methylpyridine | 179.22 |
| C14H21ClN2OS | 3-[3-(dimethylamino)propyl]-2-phenyl-thiazolidin-4-one;hydrochloride | Phedmapt | 300.80 |
| C14H20N2OS | 3-[3-(dimethylamino)propyl]-2-phenyl-thiazolidin-4-one | CHEMBL1202936 | 264.39 |
| C12H12N4O | N-(3,8-dimethylimidazo[4,5-f]quinolin-2-yl)hydroxylamine | OH-Me-Iqx | 228.25 |
| C19H21Cl2NO | 3-[bis(2-chloroethyl)amino]-1-(4-phenylphenyl)propan-1-one | Toxin 5 | 350.30 |
| C19H21Br2NO | 3-[bis(2-bromoethyl)amino]-1-(4-phenylphenyl)propan-1-one | Toxin 6 | 439.20 |
| C9H12N4O2 | (4-carbamoylphenyl)-(dimethylhydrazono)-oxido-ammonium | CID 126628 | 208.22 |
| C9H20N4O3 | methyl N-(3-aminopropyl)-N-[[2-(dimethylamino)-2-oxo-ethyl]amino]carbamate | methyl N-(3-aminopropyl)-N-[[2-(dimethylamino)-2-oxo-ethyl]amino]carbamate | 232.28 |
| C13H19N5O5 | (4-nitrophenyl) N-(3-aminopropyl)-N-(dimethylcarbamoylamino)carbamate | Ndcaonp | 325.32 |
| C14H22N4O3 | phenyl N-(4-aminobutyl)-N-(dimethylcarbamoylamino)carbamate | Nndcalp | 294.35 |
| C14H21N5O5 | (4-nitrophenyl) N-(4-aminobutyl)-N-(dimethylcarbamoylamino)carbamate | Ndcanp | 339.35 |
| C8H13NO4 | (2S,5R)-3,3-dimethylpyrrolidine-2,5-dicarboxylic acid | (2S,5R)-3,3-dimethylpyrrolidine-2,5-dicarboxylic acid | 187.19 |
| C11H15N5O2 | (1R,4S,5S)-4-(6-amino-7,8-dihydropurin-9-yl)-5-(hydroxymethyl)cyclopent-2-en-1-ol | (1R,4S,5S)-4-(6-amino-7,8-dihydropurin-9-yl)-5-(hydroxymethyl)cyclopent-2-en-1-ol | 249.27 |
| C8H8F2N4O5 | 5-fluoro-5-(5-fluoro-2,4-dioxo-hexahydropyrimidin-1-yl)-6-hydroxy-hexahydropyrimidine-2,4-dione | 5-fluoro-5-(5-fluoro-2,4-dioxo-hexahydropyrimidin-1-yl)-6-hydroxy-hexahydropyrimidine-2,4-dione | 278.17 |
| C13H15FN4O5 | 9-[(6R)-4-fluoro-6-(hydroxymethyl)-5-oxo-2H-pyran-2-yl]-1,3-dimethyl-4,5-dihydropurine-2,6-dione | 9-[(6R)-4-fluoro-6-(hydroxymethyl)-5-oxo-2H-pyran-2-yl]-1,3-dimethyl-4,5-dihydropurine-2,6-dione | 326.28 |
| C30H40N3O12P | [2-[(8S,9S,10R,13S,14S,17R)-17-[[(2R,3S,4S,5R)-5-(4-amino-2-oxo-pyrimidin-1-yl)-3,4-dihydroxy-tetrahydrofuran-2-yl]methoxy]-10,13-dimethyl-3,11-dioxo-1,2,6,7,8,9,12,14,15,16-decahydrocyclopenta[a]phenanthren-17-yl]-2-oxo-ethyl] dihydrogen phosphate | Cortisone-p-ara-C | 665.60 |
| C11H21NO9 | (2S)-2-[[(2R,3R,4R,5R)-2,3,4,5,6-pentahydroxyhexyl]amino]pentanedioic acid | Mannopinic acid | 311.29 |
| C21H21FN2O8 | [(2R,3S,5R)-3-acetoxy-5-[5-fluoro-3-(3-methylbenzoyl)-2,4-dioxo-pyrimidin-1-yl]tetrahydrofuran-2-yl]methyl acetate | 74596-17-1 | 448.40 |
| C10H7BrFN3O | 2-amino-5-bromo-6-(2-fluorophenyl)-1H-pyrimidin-4-one | 2-amino-5-bromo-6-(2-fluorophenyl)-1H-pyrimidin-4-one | 284.08 |
| C10H7BrFN3O | 2-amino-5-bromo-6-(3-fluorophenyl)-1H-pyrimidin-4-one | 2-amino-5-bromo-6-(3-fluorophenyl)-1H-pyrimidin-4-one | 284.08 |
| C10H7FIN3O | 2-amino-6-(3-fluorophenyl)-5-iodo-1H-pyrimidin-4-one | 2-amino-6-(3-fluorophenyl)-5-iodo-1H-pyrimidin-4-one | 331.08 |
| C31H33NO9 | [(2R,3R,4R,5R)-4-(dimethylamino)-5-hydroxy-6-(1-hydroxy-10,12-dimethoxy-6-oxo-8-vinyl-naphtho[1,2-c]isochromen-4-yl)-2-methyl-tetrahydropyran-3-yl] acetate | Ravidomycin | 563.60 |
| C19H21NO4 | (1S,5S,13R,14R,18R)-4-allyl-12,16-dioxa-4-azahexacyclo[9.7.1.01,13.05,18.07,19.015,17]nonadeca-7(19),8,10-triene-10,14-diol | (1S,5S,13R,14R,18R)-4-allyl-12,16-dioxa-4-azahexacyclo[9.7.1.01,13.05,18.07,19.015,17]nonadeca-7(19),8,10-triene-10,14-diol | 327.40 |
| C7H8N6O3 | 2-nitro-1-nitroso-1-(4-pyridylmethyl)guanidine | 2-nitro-1-nitroso-1-(4-pyridylmethyl)guanidine | 224.18 |
| C32H46N3O6P | N-cyclohexylcyclohexanamine;(2S)-1-[(2S)-2-(diphenoxyphosphorylamino)propanoyl]pyrrolidine-2-carboxylic acid | N-cyclohexylcyclohexanamine;(2S)-1-[(2S)-2-(diphenoxyphosphorylamino)propanoyl]pyrrolidine-2-carboxylic acid | 599.70 |
| C20H23N2O6P | (2S)-1-[2-(diphenoxyphosphorylamino)propanoyl]pyrrolidine-2-carboxylic acid | (2S)-1-[2-(diphenoxyphosphorylamino)propanoyl]pyrrolidine-2-carboxylic acid | 418.40 |
| C24H29N4O10P | tert-butyl (2S)-1-[(2S)-2-[bis(4-nitrophenoxy)phosphorylamino]propanoyl]pyrrolidine-2-carboxylate | tert-butyl (2S)-1-[(2S)-2-[bis(4-nitrophenoxy)phosphorylamino]propanoyl]pyrrolidine-2-carboxylate | 564.50 |
| C22H27N2O5P | (2S)-1-[(2S)-2-[[phenoxy(2-phenylethyl)phosphoryl]amino]propanoyl]pyrrolidine-2-carboxylic acid | CHEMBL30441 | 430.40 |
| C23H26Cl2N4O6 | O3-ethyl O5-methyl 2-[2-(2-amino-5-oxo-4H-imidazol-3-yl)ethoxymethyl]-4-(2,3-dichlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate | RefChem:192959 | 525.40 |
| C39H60N8O13 | (2S)-6-amino-2-[[(2S)-1-[(2S,3S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-amino-4-carboxy-butanoyl]amino]-4-carboxy-butanoyl]amino]propanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-3-methyl-pentanoyl]pyrrolidine-2-carbonyl]amino]hexanoic acid | Somatotropin (32-38) | 848.90 |
| C10H16F3N3O5S | S-[2-[[2-[(2-aminoacetyl)amino]acetyl]amino]ethyl] ethanethioate;2,2,2-trifluoroacetic acid | N-Glycylglycyl-S-acetylcysteamine trifluoroacetate | 347.31 |
| C8H15N3O3S | S-[2-[[2-[(2-aminoacetyl)amino]acetyl]amino]ethyl] ethanethioate | CHEMBL319134 | 233.29 |
| C9H12NO7P | (2S)-2-amino-3-(4-hydroxy-3-phosphonooxy-phenyl)propanoic acid | Dopa 3-phosphate | 277.17 |
| C23H25NO4 | (13aS,14R)-2,3,6-trimethoxy-9,11,12,13,13a,14-hexahydrophenanthro[9,10-f]indolizin-14-ol | Hypoestestatin 2 | 379.40 |